Biotronik announced the European launch of the Reliaty pacing system analyser, on 4 February 2011, after CE marking and successful pre-market evaluation. The pacing system analyser is used to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customised device programming during an implantation of implantable pacemakers, Implantable Cardioverter-Defibrillators (ICDs) and Cardiac Resynchronisation Therapy (CRT) systems.
“Using the Reliaty allows me to be more flexible during implant procedures. It can be set up and moved very quickly from one location to another whenever necessary”, says Richard Derksen, cardiologist at the Rijnstate Clinic Arnhem, The Netherlands. “Reliaty streamlines the workflow of procedures with a focused set of exactly the analytics that are required intraoperatively and for which I would otherwise have to use a programming device which is bulkier and less mobile, especially in the constrained space of the cath lab.”
Marlou Janssen, vice president, Global Marketing and Sales, Cardiac Rhythm Management, Biotronik, said “Reliaty is part of a completely new external device portfolio from Biotronik. Together with the new external pacemaker Reocor and the upcoming new programmer Renamic, Biotronik is setting new standards in offering the highest quality portfolio of external CRM devices.”
Reliaty now features an additional test channel that allows for testing of up three implanted cardiac leads to more easily accommodate cardiac resynchronisation therapy cases. It is battery powered to last for more than 12 hours of service daily, and additionally offers a universal stationary power cord that can be used worldwide. The measurement data can be exported from the analyser to a memory stick or printed via Bluetooth.